“…Emergence of the omicron variant, with a change in tissue tropism, precipitated the need for altered testing regimes. As compared to earlier VOCs, the omicron variant replicated rapidly in human nasal cells, albeit at lower titres than were eventually found in lung cells [ [16] , [17] , [18] , [19] ]. Omicron-infected patients have shorter incubation periods prior to symptom onset, and pre-symptomatic viral shedding in saliva has been observed in the absence of nasal shedding [ 20 , 21 ], suggesting an advantage to early viral detection in saliva.…”